Product Overview
Fresh leukopaks are a primary source of immune cells widely used as starting material for cell therapy research, process development, and manufacturing. Collected via leukapheresis, they provide a high yield of viable mononuclear cells, including T cells, NK cells, and other relevant immune subsets.
Our fresh leukopaks are sourced from a large and diverse donor network and produced under standardized collection protocols to ensure consistency, traceability, and documentation. Each leukopak is supported by comprehensive donor qualification and safety testing in alignment with applicable regulatory and ethical requirements.
With established collection capabilities across Europe and the US, our fresh leukopaks are shipped within 24 hours post collection under strict quality control and temperature regulated conditions, ensuring cellular integrity, high viability, and reliable, scalable access to consistent immune cell material, supporting a smooth transition from early stage research through clinical development and into commercial manufacturing.